Korean Treatment Guidelines for Metastatic Prostate Cancer Developed by the Korean Association for Clinical Oncology-Reference-Cited by-同舟云学术

Korean Treatment Guidelines for Metastatic Prostate Cancer Developed by the Korean Association for Clinical Oncology

Published:2017-04-01 Issue:2 Volume:92 Page:124-141
ISSN:1738-9364
Container-title:The Korean Journal of Medicine
language:en
Short-container-title:Korean J Med

Author:

Park Inkeun,Kang Byung Woog,Koh Su-Jin,Kim Kyoung Ha,Kim Se Hyun,Kim Chan Kyu,Kim Ho Young,Park Kwonoh,Park Se Hoon,Oh Sung Yong,Lee Junglim,Lee Hyo Jin,Lim Seung Taek,Jo Jae-Cheol,Lee Jae Lyun

Publisher

Korean Association of Internal Medicine

Subject

General Economics, Econometrics and Finance

Link

http://ekjm.org/upload/kjm-2017-92-2-124.pdf

Reference93 articles.

1. Prediction of Cancer Incidence and Mortality in Korea, 2015

2. Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer: 2007 Update of an American Society of Clinical Oncology Practice Guideline

3. Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer

4. Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

5. Abiraterone and Increased Survival in Metastatic Prostate Cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of a Nurse-Led Mobile-Based Health Coaching Program for Patients With Prostate Cancer at High Risk of Metabolic Syndrome: Randomized Waitlist Controlled Trial;JMIR mHealth and uHealth;2024-02-01

2. Effectiveness of a Nurse-Led Mobile-Based Health Coaching Program for Patients With Prostate Cancer at High Risk of Metabolic Syndrome: Randomized Waitlist Controlled Trial (Preprint);2023-03-22